Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Relapsed Pediatric ALL”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01700946
What this trial is testing

Therapy for Pediatric Relapsed or Refractory Precursor B-Cell Acute Lymphoblastic Leukemia and Lymphoma

Who this might be right for
Recurrent B-Cell Childhood Acute Lymphoblastic LeukemiaRecurrent Childhood B-Lymphoblastic Lymphoma
St. Jude Children's Research Hospital 80
Not applicableNo Longer AvailableNCT02187354
What this trial is testing

Expanded Access Protocol - Blinatumomab in Pediatric & Adolescent Subjects With Relapsed/Refractory B-precursor ALL

Who this might be right for
Relapsed/Refractory B-Precursor Acute Lymphoblastic Leukemia
Amgen
Early research (Phase 1)Study completedNCT01861002
What this trial is testing

A Phase I Study of 5-Azacytidine in Combination With Chemotherapy for Children With Relapsed or Refractory ALL or AML

Who this might be right for
Lymphoblastic Leukemia, Acute, ChildhoodMyelogenous Leukemia, Acute, Childhood
Therapeutic Advances in Childhood Leukemia Consortium 15
Testing effectiveness (Phase 2)Study completedNCT04325841
What this trial is testing

Phase II Study of Anti-CD19 CAR-T Cells Treating Leukemia Children

Who this might be right for
Acute Lymphoblastic Leukemia, PediatricAcute Lymphoblastic Leukemia, in RelapseRefractory Acute Lymphoblastic Leukemia
Beijing Boren Hospital 2
Early research (Phase 1)WithdrawnNCT05134740
What this trial is testing

(TAA)-Specific Cytotoxic T-Lymphocytes to Pediatric Patients With Lymphomas (pediTACTAL).

Who this might be right for
Hodgkins LymphomaNon Hodgkins Lymphoma
Baylor College of Medicine
Testing effectiveness (Phase 2)Ended earlyNCT02332889
What this trial is testing

Phase I/II: Decitabine/Vaccine Therapy in Relapsed/Refractory Pediatric High Grade Gliomas/Medulloblastomas/CNS PNETs

Who this might be right for
GliomasMedulloblastomaNeuroectodermal Tumors, Primitive
University of Louisville 1
Testing effectiveness (Phase 2)Active Not RecruitingNCT05210413
What this trial is testing

Spartalizumab and Low-dose PAzopanib in Refractory or Relapsed Solid TumOrs of Pediatric and Adults

Who this might be right for
Refractory or Recurrent Solid Tumor
University Hospital, Bordeaux 80
Testing effectiveness (Phase 2)Looking for participantsNCT06013618
What this trial is testing

Clinical Analysis of Naxitamab (hu3F8) in the Treatment of Pediatric High Risk or Refractory/ Relapsed Neuroblastoma

Who this might be right for
Neuroblastoma
Sun Yat-Sen University Cancer Center 120
Testing effectiveness (Phase 2)Active Not RecruitingNCT05421897
What this trial is testing

Rapid Administration Pilot for Infusing Dinutuximab

Who this might be right for
Neuroblastoma
Children's Hospital Los Angeles 30
Testing effectiveness (Phase 2)Study completedNCT00930098
What this trial is testing

A Phase II, Open-Label Study of Clofarabine in Paediatric Patients With Refractory/Relapsed Acute Lymphoblastic Leukaemia

Who this might be right for
Acute Lymphoblastic Leukemia
Genzyme, a Sanofi Company 74
Early research (Phase 1)Study completedNCT02677116
What this trial is testing

Olaratumab Alone and in Combination With Standard Chemotherapies in Children With Cancer

Who this might be right for
Neoplasm Metastasis
Eli Lilly and Company 68
Large-scale testing (Phase 3)Study completedNCT03123939
What this trial is testing

Phase III B in Acute Lymphoblastic Leukemia

Who this might be right for
Acute Lymphoblastic Leukemia
Novartis Pharmaceuticals 69
Early research (Phase 1)Not Yet RecruitingNCT07331064
What this trial is testing

Gallium Maltolate for the Treatment of Pediatric Patients With Relapsed or Refractory Pediatric High-Grade Glioma and Atypical Teratoid Rhabdoid Tumor

Who this might be right for
High Grade GliomasAtypical Teratoid Rhabdoid Tumors (ATRT)Diffuse Midline Glioma+2 more
Sarah Rumler 15
Testing effectiveness (Phase 2)Looking for participantsNCT05533775
What this trial is testing

Evaluate Glofitamab Monotherapy and Glofitamab + Chemoimmunotherapy in Pediatric and Young Adult Participants With Relapsed/Refractory Mature B-Cell Non-Hodgkin Lymphoma

Who this might be right for
Mature B-Cell Non-Hodgkin Lymphoma
Hoffmann-La Roche 65
Testing effectiveness (Phase 2)Study completedNCT00186875
What this trial is testing

Therapy for Pediatric Relapsed or Refractory Acute Lymphoblastic Leukemia

Who this might be right for
Acute Lymphoblastic LeukemiaLymphoma, Lymphoblastic
St. Jude Children's Research Hospital 47
Testing effectiveness (Phase 2)Ended earlyNCT03458728
What this trial is testing

Safety, Tolerability, Efficacy and Pharmacokinetics of Copanlisib in Pediatric Patients

Who this might be right for
Relapsed or Refractory Solid Tumors or Lymphoma in ChildrenNeuroblastomaOsteosarcoma+2 more
Bayer 31
Large-scale testing (Phase 3)Active Not RecruitingNCT03958877
What this trial is testing

Evaluate the Safety, Tolerability, and Efficacy of BIIB017 (Peginterferon Beta-1a) in Pediatric Participants for the Treatment of Relapsing-Remitting Multiple Sclerosis

Who this might be right for
Multiple Sclerosis, Relapsing-Remitting
Biogen 152
Large-scale testing (Phase 3)Looking for participantsNCT07375563
What this trial is testing

Chemoimmunotherapy Combined With Autologous NK Cell Therapy for Pediatric Patients With Refractory and Relapsed High-Risk Neuroblastoma and Ganglioneuroblastoma

Who this might be right for
Neuroblastoma (NB)Ganglioneuroblastoma
Federal Research Institute of Pediatric Hematology, Oncology and Immunology 5
Early research (Phase 1)WithdrawnNCT06474663
What this trial is testing

A Phase I Study Investigating the Combination of Cladribine, Low Dose Cytarabine and Sorafenib Alternating With Decitabine in Pediatric Relapsed and Refractory Acute Leukemias

Who this might be right for
Refractory Acute LeukemiaRelapsed Acute Leukemia
M.D. Anderson Cancer Center
Early research (Phase 1)Study completedNCT00786669
What this trial is testing

A Pilot Study of the Addition of Bevacizumab to VOIT Regimen for Relapsed/Refractory Pediatric Solid Tumors

Who this might be right for
Solid Tumor
Children's Hospital Medical Center, Cincinnati 13
Next Page